Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysis

BACKGROUND: Although previous studies have demonstrated the clinical benefits of dalfampridine extended release (D-ER) tablets in patients with multiple sclerosis (MS), there are limited real-world data on D-ER utilization and associated outcomes in patients with MS. PURPOSE: The objective of this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Amy, Grabner, Michael, Palli, Swetha Rao, Elder, Jessica, Sidovar, Matthew, Aupperle, Peter, Krieger, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869620/
https://www.ncbi.nlm.nih.gov/pubmed/27274292
http://dx.doi.org/10.2147/CEOR.S99750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869620/
https://www.ncbi.nlm.nih.gov/pubmed/27274292
http://dx.doi.org/10.2147/CEOR.S99750

Ejemplares similares